Chengliang Yang

Chengliang Yang

Auto-generated profile, based on publicly available information

Chengliang Yang

Prevention of Organ Failure (PROOF) Centre of Excellence, St. Paul's Hospital, Vancouver, BC, Canada; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada; Providence Research, Providence Health Care, Vancouver, BC, Canada; Department of Medicine, University of British Columbia, Vancouver, BC, Canada

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CYCheng-Liang Yang
Cheng-Liang Yang
Yong-Yu LiuYong-Yu Liu
Yong-Yu Liu
YMYe-Gang Ma
Ye-Gang Ma
YXYi-Xue Xue
Yi-Xue Xue
DLDe-Gui Liu
De-Gui Liu
ZLZhen Li
Zhen Li
Curcumin, the active component of turmeric, has been shown to protect against carcinogenesis and prevent tumor development. However, little is known about its anti-tumor mechanism in small cell lung cancer (SCLC). In this study, we found that curcumin can inhibit SCLC cell proliferation, cell cycle, migration, invasion and angiogenesis through suppression of the STAT3. SCLC cells were treated with curcumin (15 µmol/L) and the results showed that curcumin was effective in inhibiting STAT3 phosphorylation to downregulate of an array of STAT3 downstream targets ,which contributed to suppression of cell proliferation, loss of colony formation, depression of cell migration and invasion. Curcumin also suppressed the expression of proliferative proteins (Survivin, Bcl-XL and Cyclin B1), and invasive proteins (VEGF, MMP-2, MMP-7 and ICAM-1).Knockdown of STAT3 expression by siRNA was able to induce anti-invasive effects in vitro. In contrast, activation of STAT3 upstream of interleukin 6 (IL-6) leads to the increased cell proliferation ,cell survival, angiogenesis, invasion, migration and tumor growth. Our findings illustrate the biologic significance of IL-6/JAK/STAT3 signaling in SCLC progression and providenovel evidence that the pathway may be a new potential target for therapy of SCLC. It was concluded that curcumin is a potent agent in the inhibition of STAT3 with favorable pharmacological activity,and curcumin may have translational potential as an effective cancer therapeutic or preventive agent for SCLC.

8 April 2023 in EBioMedicine
Verified
Journal Article
Open access
EEEstefanía Espín
Estefanía Espín
CYChengliang Yang
Chengliang Yang
CSCasey P. Shannon
Casey P. Shannon
SASara Assadian
Sara Assadian
DHDaniel He
Daniel He
STScott J. Tebbutt
Scott J. Tebbutt
Long-COVID (LC) encompasses diverse symptoms lasting months after the initial SARS-CoV-2 infection. Symptoms can be debilitating and affect the quality of life of individuals with LC and their families. Although the symptoms of LC are well described, the aetiology of LC remains unclear, and consequently, patients may be underdiagnosed. Identification of LC specific biomarkers is therefore paramount for the diagnosis and clinical management of the syndrome. This scoping review describes the molecular and cellular biomarkers that have been identified to date with potential use for diagnosis or prediction of LC. This review was conducted using the Joanna Briggs Institute (JBI) Methodology for Scoping Reviews. A search was executed in the MEDLINE and EMBASE databases, as well as in the grey literature for original studies, published until October 5th, 2022, reporting biomarkers identified in participants with LC symptoms (from all ages, ethnicities, and sex), with a previous infection of SARS-CoV-2. Non-English studies, cross-sectional studies, studies without a control group, and pre-prints were excluded. Two reviewers independently evaluated the studies, extracted population data and associated biomarkers. 23 cohort studies were identified, involving 2163 LC patients [median age 51.8 years, predominantly female sex (61.10%), white (75%), and non-vaccinated (99%)]. A total of 239 candidate biomarkers were identified, consisting mainly of immune cells, immunoglobulins, cytokines, and other plasma proteins. 19 of the 239 candidate biomarkers identified were evaluated by the authors, by means of receiver operating characteristic (ROC) curves. Diverse cellular and molecular biomarkers for LC have been proposed. Validation of candidate biomarkers in independent samples should be prioritized. Modest reported performance (particularly in larger studies) suggests LC may encompass many distinct aetiologies, which should be explored e.g., by stratifying by symptom clusters and/or sex. Dr. Tebbutt has received funding from the 10.13039/501100000024 Canadian Institutes of Health Research (177747) to conduct this work. The funding source was not involved in this scoping review, or in the decision to submit this manuscript for publication.

1 February 2012 in DNA and Cell Biology
Verified
Journal Article
Closed access
CYCheng-Liang Yang
Cheng-Liang Yang
YMYe-Gang Ma
Ye-Gang Ma
YXYi-Xue Xue
Yi-Xue Xue
Yong-Yu LiuYong-Yu Liu
Yong-Yu Liu
HXHui Xie
Hui Xie
GQGuang-Rong Qiu
Guang-Rong Qiu
Curcumin (diferuloylmethane), an active component of the spice turmeric, induces apoptosis in several types of malignancies. However, little is known about its anticancer activity in small cell lung cancer (SCLC). SCLC represents a highly malignant and particularly aggressive form of cancer, with early and widespread metastases and a poor prognosis. In this study, we found that curcumin does not activate caspase-8 cleavage or alter the expression of apoptotic receptors FAS and TRAIL in NCI-H446 cells, suggesting that curcumin-induced apoptosis is not associated with death receptor-mediated pathways in these cells. Instead, curcumin caused apoptosis by increasing Bax expression while decreasing the expression of Bcl-2 and Bcl-xL. Curcumin induced a rapid decrease in mitochondrial membrane potential and the release of cytochrome c into the cytosol, followed by activation of caspase-9 and caspase-3. In addition, curcumin-induced apoptosis was accompanied by an increase of intracellular reactive oxygen species (ROS) level. These results indicated that a ROS-mediated mitochondrial pathway played an important role in the process of curcumin-induced apoptosis of human SCLC NCI-H446 cells.

23 May 2014 in Inflammation
Verified
Journal Article
Closed access
PDF file
LZLiang Zhang
Liang Zhang
YRYi Ren
Yi Ren
CYChengliang Yang
Chengliang Yang
YGYue Guo
Yue Guo
XZXiaojing Zhang
Xiaojing Zhang
YLYongyu Liu
Yongyu Liu

11 March 2023 in The Lancet Regional Health - Europe
Verified
Journal Article
Open access
CYChengliang Yang
Chengliang Yang
STScott J. Tebbutt
Scott J. Tebbutt

1 April 2016 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
CYCheng-Liang Yang
Cheng-Liang Yang
WWWei Wang
Wei Wang
LMLil-Li Mo
Lil-Li Mo
LZLiang Zhang
Liang Zhang
GPGui-Lin Peng
Gui-Lin Peng
JHJianxing He
Jianxing He